These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3119486)

  • 1. Interactions between exogenous fat and plasma/lipoproteins.
    Carpentier YA; Richelle M; Bihain BE; Dahlan W; Haumont D; Deckelbaum RJ
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 3():29-32. PubMed ID: 3119486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fat emulsions are more than energy suppliers.
    Carpentier YA; Bihain BE; Deckelbaum RJ
    Infusionsther Klin Ernahr; 1986 Aug; 13(4):182-4. PubMed ID: 3531009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous infusions of commercial fat emulsions (Intralipid 10 or 20%) on rat plasma lipoproteins: phospholipids in excess are the main precursors of lipoprotein-X-like particles.
    Hajri T; Férézou J; Lutton C
    Biochim Biophys Acta; 1990 Nov; 1047(2):121-30. PubMed ID: 2248969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lipoprotein pattern during long-term home parenteral nutrition with two lipid emulsions.
    Richelle M; Rubin M; Kulapongse S; Deckelbaum RJ; Elwyn DH; Carpentier YA
    JPEN J Parenter Enteral Nutr; 1993; 17(5):432-7. PubMed ID: 8289409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appearance and characterization of lipoprotein X during continuous intralipid infusions in the neonate.
    Griffin E; Breckenridge WC; Kuksis A; Bryan MH; Angel A
    J Clin Invest; 1979 Dec; 64(6):1703-12. PubMed ID: 227938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of transfer of apolipoproteins between triacylglycerol-rich particles in lipid emulsions and plasma lipoproteins.
    Iriyama K; Carpentier YA
    Nutrition; 1994; 10(3):252-4. PubMed ID: 7919678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and metabolic fate of triacylglycerol- and phospholipid-rich particles of commercial parenteral fat emulsions.
    Ferezou J; Bach AC
    Nutrition; 1999 Jan; 15(1):44-50. PubMed ID: 9918062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and metabolic tolerance of a concentrated long-chain triglyceride lipid emulsion in critically ill septic and trauma patients.
    García-de-Lorenzo A; López-Martínez J; Planas M; Chacón P; Montejo JC; Bonet A; Ortiz-Leyba C; Sánchez-Segura JM; Ordóñez J; Acosta J; Grau T; Jiménez FJ
    JPEN J Parenter Enteral Nutr; 2003; 27(3):208-15. PubMed ID: 12757115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer of apolipoproteins between plasma lipoproteins and exogenous lipid particles after repeated bolus injections or during a continuous infusion of fat emulsion.
    Tonouchi H; Iriyama K; Carpentier YA
    JPEN J Parenter Enteral Nutr; 1990; 14(4):381-5. PubMed ID: 2119445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of fat emulsion on serum lipids in postoperative patients.
    Meguid MM; Kurzer M; Hayashi RJ; Akahoshi MP
    JPEN J Parenter Enteral Nutr; 1989; 13(1):77-80. PubMed ID: 2494371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in serum lipoproteins in humans following the infusion of a fat emulsion containing medium- and long-chain triglycerides.
    Hailer S; Wolfram G; Zöllner N
    Eur J Clin Invest; 1987 Oct; 17(5):402-7. PubMed ID: 3121343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incubation of lipid emulsions with plasma lipoproteins modifies the fluidity of each particle.
    Chanson NF; Lontie JF; Carpentier YA; Motta C
    Lipids; 2001 Aug; 36(8):819-25. PubMed ID: 11592733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low density lipoproteins (LDL) heterogeneity and intravenous fat in neonates.
    Genzel-Boroviczény O; D'Harlingue A; Forte T
    Eur J Med Res; 1996 Apr; 1(7):315-20. PubMed ID: 9364031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein C-II modifications associated with an infusion of artificial lipid particles.
    Iriyama K; Nishiwaki H; Terashima H; Tonouchi H; Miki C; Suzuki H; Carpentier YA
    JPEN J Parenter Enteral Nutr; 1988; 12(1):60-2. PubMed ID: 3125357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disturbances of lipoprotein and fatty acid metabolism in patients with heavy injuries (author's transl)].
    Wolfram G; Eckart J; Zöllner N
    Klin Wochenschr; 1980 Dec; 58(24):1327-37. PubMed ID: 6782330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phospholipids as emulsifiers in fat emulsions--effect on phospholipids in the serum lipoprotein fraction d greater than 1.063].
    Hailer S; Kalb S; Wolfram G
    Z Ernahrungswiss; 1988 Mar; 27(1):23-9. PubMed ID: 3376501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipid and plasma lipoprotein concentrations in low birth weight infants given parenteral nutrition with twenty or ten percent lipid emulsion.
    Haumont D; Deckelbaum RJ; Richelle M; Dahlan W; Coussaert E; Bihain BE; Carpentier YA
    J Pediatr; 1989 Nov; 115(5 Pt 1):787-93. PubMed ID: 2809914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralipid clearance and lipoprotein pattern in men with advanced alcoholic liver cirrhosis.
    Rössner S; Johansson C; Walldius G; Aly A
    Am J Clin Nutr; 1979 Oct; 32(10):2022-6. PubMed ID: 225949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clearance and utilization of infused fat emulsions].
    Wolfram G
    Infusionsther Klin Ernahr; 1983 Jun; 10(3):120-6. PubMed ID: 6350175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distribution and elimination of medium- and long-chain fatty acids of a fat emulsion in lipoproteins of severely injured patients following bolus injection].
    Wolfram G; Adolph M; Eckart J
    Z Ernahrungswiss; 1989 Jun; 28(2):173-80. PubMed ID: 2503947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.